Therefore, until drugs effective against COVID-19 viruses are developed, drugs for type II diabetes such as DPP4 inhibitors and GLP-1 may protect COVID-19 patients from severe symptoms by improving endothelial damage and inhibiting EndoMT. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.